X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB FDC LTD. UNICHEM LAB/
FDC LTD.
 
P/E (TTM) x -66.4 22.7 - View Chart
P/BV x 0.7 5.1 14.6% View Chart
Dividend Yield % 2.3 0.9 245.4%  

Financials

 UNICHEM LAB   FDC LTD.
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
FDC LTD.
Mar-14
UNICHEM LAB/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs382144 266.2%   
Low Rs23479 296.3%   
Sales per share (Unadj.) Rs116.347.6 244.5%  
Earnings per share (Unadj.) Rs-18.97.6 -248.7%  
Cash flow per share (Unadj.) Rs-11.79.0 -130.3%  
Dividends per share (Unadj.) Rs5.002.25 222.2%  
Dividend yield (eoy) %1.62.0 80.3%  
Book value per share (Unadj.) Rs381.047.5 801.6%  
Shares outstanding (eoy) m70.34177.83 39.6%   
Bonus/Rights/Conversions BBBB-  
Price / Sales ratio x2.62.3 113.3%   
Avg P/E ratio x-16.314.6 -111.4%  
P/CF ratio (eoy) x-26.212.3 -212.5%  
Price / Book Value ratio x0.82.3 34.5%  
Dividend payout %-26.429.6 -89.4%   
Avg Mkt Cap Rs m21,66819,784 109.5%   
No. of employees `0002.3NA-   
Total wages/salary Rs m2,0061,221 164.4%   
Avg. sales/employee Rs Th3,587.8NM-  
Avg. wages/employee Rs Th880.0NM-  
Avg. net profit/employee Rs Th-583.7NM-  
INCOME DATA
Net Sales Rs m8,1808,459 96.7%  
Other income Rs m610394 155.0%   
Total revenues Rs m8,7908,852 99.3%   
Gross profit Rs m-1,3202,070 -63.8%  
Depreciation Rs m505249 202.8%   
Interest Rs m8031 258.3%   
Profit before tax Rs m-1,2952,184 -59.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-225 1.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m33606 5.5%   
Profit after tax Rs m-1,3311,353 -98.4%  
Gross profit margin %-16.124.5 -65.9%  
Effective tax rate %-2.627.7 -9.3%   
Net profit margin %-16.316.0 -101.7%  
BALANCE SHEET DATA
Current assets Rs m23,3184,355 535.4%   
Current liabilities Rs m4,6351,792 258.7%   
Net working cap to sales %228.430.3 753.6%  
Current ratio x5.02.4 207.0%  
Inventory Days Days12244 273.9%  
Debtors Days Days12125 492.5%  
Net fixed assets Rs m8,1633,025 269.9%   
Share capital Rs m141179 78.8%   
"Free" reserves Rs m26,6608,243 323.4%   
Net worth Rs m26,8018,453 317.1%   
Long term debt Rs m311 30.8%   
Total assets Rs m31,89010,557 302.1%  
Interest coverage x-15.271.4 -21.2%   
Debt to equity ratio x00 9.7%  
Sales to assets ratio x0.30.8 32.0%   
Return on assets %-3.913.1 -29.9%  
Return on equity %-5.016.0 -31.0%  
Return on capital %-4.523.5 -19.3%  
Exports to sales %013.3 0.0%   
Imports to sales %03.3 0.0%   
Exports (fob) Rs mNA1,126 0.0%   
Imports (cif) Rs mNA283 0.0%   
Fx inflow Rs m4,3561,146 380.1%   
Fx outflow Rs m0355 0.0%   
Net fx Rs m4,356791 550.9%   
CASH FLOW
From Operations Rs m-1,1231,485 -75.7%  
From Investments Rs m16,487-620 -2,661.3%  
From Financial Activity Rs m-8,811-753 1,170.9%  
Net Cashflow Rs m6,552113 5,808.5%  

Share Holding

Indian Promoters % 50.1 68.9 72.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 4.7 321.3%  
FIIs % 3.0 7.5 40.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 19.0 166.8%  
Shareholders   20,176 23,730 85.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare UNICHEM LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 290 Points; Realty and PSU Stocks Witness Selling(Closing)

After opening the day on a negative note, share markets in India continued their downtrend throughout the day and ended in red.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

As the Rupee Takes a Record Plunge, These Pharma Stocks Gain the Most(Sector Info)

Sep 5, 2018

Most pharma stocks were trading with gains amid rupee's fresh fall. Does that mean pharma stocks are back in vogue?

Why Arun Jaitley's Demonetisation Defence Doesn't Add Up(Vivek Kaul's Diary)

Sep 5, 2018

The tax collected has gone up a little but the question is at what cost.

The Cream of Small Cap Stocks(Profit Hunter)

Sep 5, 2018

Akin to skimming the cream off milk, one needs to learn to skim the cream off small cap stocks.

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 18, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - GSK PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS